Lifeboat Foundation

Arab American University congrats and is proud of Dr. Thabat Al-Khatib and researcher in Applied Neuroscience, Dr. Al-Khatib graduated from the Faculty of Sciences and Arts at Arab American University in 2012. She succeeded to add her name on the list of innovators in Britain after the invention of a drug treatment for Alzheimer’s disease and received two patents.

Al Khatib is currently working at the University of Aberdeen – Faculty of Medicine as a researcher in Neuroscience dept. and aspires to be a lecturer in Palestine to add value to students and the community.

Al-Khatib said commenting on the two inventions:

Continue reading “The University Is Proud and Congratulates Its Graduate Dr. Thabat Al-khatib and Researcher in Applied Neuroscience for Receiving Two Patents of Medicine for the Treatment of Alzheimer’s Disease” »

Biomedical pictures for April 2019.

Patients recovering from a stroke can slash their risk of blood clots by wearing a small “half wrist-watch” around their leg, a trial has shown.

A study at Royal Stoke University Hospital found the geko device could reduces the risk of clots compared to standard treatment, is comfortable to wear and could save the NHS cash.

Approved for use on the NHS for other conditions, the geko is a battery-powered, disposable, device designed to increase blood flow in the deep veins of the legs.

Continue reading “Small ‘half-watch’ worn on leg could transform recovery from stroke” »

In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells. The work puts scientists a step closer, they say, to injecting such artificial lymph nodes into people and sparking T-cells to fight disease.

In the past few years, a wave of discoveries has advanced new techniques to use T-cells – a type of white blood cell – in cancer treatment. To be successful, the cells must be primed, or taught, to spot and react to molecular flags that dot the surfaces of cancer cells. The job of educating T-cells this way typically happens in lymph nodes, small, bean-shaped glands found all over the body that house T-cells. But in patients with cancer and immune system disorders, that learning process is faulty, or doesn’t happen.

To address such defects, current T-cell booster therapy requires physicians to remove T-cells from the blood of a patient with cancer and inject the cells back into the patient after either genetically engineering or activating the cells in a laboratory so they recognize cancer-linked molecular flags.

Continue reading “Scientists advance Creation of ‘Artificial Lymph node’ to fight Cancer, other diseases” »

A medical miracle happened about 170 years ago when scientists discovered general anesthesia that enables millions of patients to undergo invasive, life-saving surgeries without pain. However, in spite of decades of research, scientists cannot understand why general anesthesia works.

In a new study published online in Neuron, scientists believe they have discovered the part of the answer. A team of researchers from a Duke University found that several different general anesthesia drugs knock out the patient by hijacking the neural circuitry that the person falls asleep.

They traced this neural circuitry to a tiny cluster of cells at the base of the brain responsible for churning out hormones to regulate bodily functions, moods, and sleep. The discovery is one of the first to indicate a role for the hormones in maintaining the state of general anesthesia and provides valuable insights for generating newer drugs that could put people to sleep with fewer side effects.

Continue reading “Scientists Discovered Where Anesthesia Works On the Brain” »

Rochester researchers have uncovered more evidence that the key to the “Fountain of Youth” may reside in a gene that is found to produce more potent proteins in species with longer lifespans. (Getty Images photo)

Share to Facebook Facebook.

The health benefits of raw, unprocessed honey are well known, but in Australia, scientists recently made a startling discovery – that one particular, obscure type of honey is capable of killing just about everything scientists throw at it, including some of the worst bacteria known to man.

The findings were published in the European Journal of Clinical Microbiology and Infectious Diseases (June 2009 edition), and could hold special significance at a time when many of the world’s top antibiotics are failing, especially against resistant “superbugs”.

The honey in question is known as manuka honey, which is produced in New Zealand and also goes by the name of jelly bush honey.

Continue reading “Manuka Honey Is Killing Every Kind Of Bacteria Scientists Throw At It, Even The Super-Bugs” »

On July 11–12, we will be hosting our second annual Ending Age-Released Diseases conference. This conference focuses on the progress of aging research along with the business and investment side of rejuvenation biotechnology.

Aging research is on the cusp of some major breakthroughs in the battle against age-related diseases, and we invite you to join us for an action-packed event filled with exciting talks and discussion panels featuring some of the leaders of aging research and the biotech business.

Continue reading “Ending Age-Related Diseases Conference: April Update” »

Almost one in ten heart attacks and strokes could be avoided if check-ups were targeted at high risk patients, new research has revealed.

People aged 40 and over in England and Wales are currently eligible to have their heart health assessed every five years.

Blood pressure, cholesterol, blood-sugar levels, smoker status, age and family history are factors considered by doctors when working out a person’s chance of having a heart attack or stroke.

Continue reading “Almost one in ten heart attacks could be prevented if high-risk patients were checked more” »